Found: 6
Select item for more details and to access through your institution.
Fractalkine Signalling (CX 3 CL1/CX 3 CR1 Axis) as an Emerging Target in Coronary Artery Disease.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 14, p. 4821, doi. 10.3390/jcm12144821
- By:
- Publication type:
- Article
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction.
- Published in:
- GeroScience, 2023, v. 45, n. 4, p. 2689, doi. 10.1007/s11357-023-00794-6
- By:
- Publication type:
- Article
Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes postmyocardial infarction.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1177467
- By:
- Publication type:
- Article
Rapid fall in circulating non‐classical monocytes in ST elevation myocardial infarction patients correlates with cardiac injury.
- Published in:
- FASEB Journal, 2021, v. 35, n. 5, p. 1, doi. 10.1096/fj.202100240R
- By:
- Publication type:
- Article
The Fractalkine Receptor CX<sub>3</sub>CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.605857
- By:
- Publication type:
- Article
Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST-Elevation Myocardial Infarction.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 18, p. 1, doi. 10.1161/JAHA.123.030473
- By:
- Publication type:
- Article